The Deal
Saturday, July 4, 
2:23 am

New VP's at InterOP, Gene Network Sciences and SkinMedica

Posted on July 27, 2006 at 10:26 AM
Filed under: Movers & Shakers
[ Share ]  [ E-mail ]  [ Leave a Comment ]
CDladder.png

InterOP Technologies, a service provider of mobile data solutions, has named Steven Reeves the firm's new vice president for sales and business development. He comes to the Fort Meyers, Fla.-based company from the Boston Communications Group, where he was executive director of business development. Reeves joined BCGI in 1997 and was responsible for managing sales and strategic partnerships.

Zach Pitluk will be responsible for driving commercial opportunities and strategic partnerships for Gene Network Sciences as vice president of business development. Pitluk joins GNS from Definiens AG, a provider of enterprise image intelligence solutions, where he served as the North America life sciences business manager.

Theodore Ebel has become vice president of business development at privately-held specialty pharmaceutical company SkinMedica Inc. of California. Ebel will look for marketed and development-stage dermatology products to acquire and will also lead the partnering activities to acquire or license patented topical drug delivery technologies. — Baz Hiralal



Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Decade of The Deal

Corporate Dealmaker Video


Vanterra's Shad Azimi on PE's evolution

Vanterra Capital's Azimi on how PE firms are investing in management to increase the value of their portfolio companies.


Movers & Shakers


Cuong Viet Do
Tyco Electronics Ltd.

Ram Ramakrishnan
Millipore Corp.

Cliff Miller
DeviceVM Inc.

Sam Wick
News Corp.

Arturo Gomez
Purfresh Inc.
Cuong Viet Do, Tyco Electronics Ltd.
Ram Ramakrishnan, Millipore Corp.
Cliff Miller, DeviceVM Inc.
Sam Wick, News Corp.
Arturo Gomez, Purfresh Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.